Loading...

Andrew F Leuchter

Title(s)Professor, Psychiatry and Biobehavioral Sciences
SchoolMedicine
Phone50207
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    UCLA Clinical Pharmacology Training Program
    NIH/NIGMS T32GM075776Jul 1, 2006 - Jun 30, 2016
    Role: Co-Principal Investigator
    Psychobiologic Factors of the Placebo Response in MDD
    NIH/NCCIH R01AT002479Sep 29, 2004 - Jun 30, 2009
    Role: Principal Investigator
    ENHANCING TREATMENT OUTCOMES IN DEPRESSION
    NIH/NIMH K02MH001165Dec 1, 1994 - Nov 30, 2005
    Role: Principal Investigator
    GERIATRIC MENTAL HEALTH ACADEMIC AWARD
    NIH/NIMH K07MH000665Aug 1, 1986 - Jul 31, 1989
    Role: Principal Investigator
    MENTAL ILLNESS IN THE ELDERLY--DIAGNOSTIC TESTING
    NIH/NIMH R01MH040705Mar 1, 1986 - Jun 30, 2001
    Role: Principal Investigator
    Research Training: Psychobiological Sciences
    NIH/NIMH T32MH017140Sep 30, 1983 - Mar 31, 2003
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cook IA, Wilson AC, Peters JM, Goyal MN, Bebin EM, Northrup H, Krueger D, Leuchter AF, Sahin M. EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex. J Autism Dev Disord. 2020 Mar; 50(3):916-923. PMID: 31811616.
      View in: PubMed
    2. Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. J Psychiatr Res. 2020 May; 124:159-165. PMID: 32169689.
      View in: PubMed
    3. Hunter AM, Leuchter AF. Benzodiazepine Use and rTMS Outcome. Am J Psychiatry. 2020 Feb 01; 177(2):172. PMID: 32008397.
      View in: PubMed
    4. Corlier J, Burnette E, Wilson AC, Lou JJ, Landeros A, Minzenberg MJ, Leuchter AF. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control. J Affect Disord. 2020 Mar 15; 265:272-277. PMID: 32090751.
      View in: PubMed
    5. Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cereb Cortex. 2019 Dec 17; 29(12):4958-4967. PMID: 30953441.
      View in: PubMed
    6. Levitt JG, Kalender G, O’Neill J, Diaz JP, Cook IA, Ginder N, Krantz D, Minzenberg MJ, Vince-Cruz N, Nguyen LD, Alger JR, Leuchter AF. Dorsolateral prefrontal ?-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy J Psychiatry Neurosci. 2019 Nov 01; 44(6):386-394. PMID: 31199104.
      View in: PubMed
    7. Cook IA, Congdon E, Krantz DE, Hunter AM, Coppola G, Hamilton SP, Leuchter AF. Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. Front Genet. 2019; 10:870. PMID: 31620172.
      View in: PubMed
    8. Corlier J, Carpenter LL, Wilson AC, Tirrell E, Gobin AP, Kavanaugh B, Leuchter AF. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Brain Stimul. 2019 Nov - Dec; 12(6):1572-1578. PMID: 31378603.
      View in: PubMed
    9. Davis PE, Kapur K, Filip-Dhima R, Trowbridge SK, Little E, Wilson A, Leuchter A, Bebin EM, Krueger D, Northrup H, Wu JY, Sahin M, Peters JM. Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex. Epilepsia. 2019 Aug; 60(8):1721-1732. PMID: 31297797.
      View in: PubMed
    10. Jain FA, Connolly CG, Moore LC, Leuchter AF, Abrams M, Ben-Yelles RW, Chang SE, Ramirez Gomez LA, Huey N, Lavretsky H, Iacoboni M. Grief, Mindfulness and Neural Predictors of Improvement in Family Dementia Caregivers. Front Hum Neurosci. 2019; 13:155. PMID: 31156412.
      View in: PubMed
    11. Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain Behav. 2019 05; 9(5):e01275. PMID: 30941915.
      View in: PubMed
    12. McGough JJ, Sturm A, Cowen J, Tung K, Salgari GC, Leuchter AF, Cook IA, Sugar CA, Loo SK. Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019 04; 58(4):403-411.e3. PMID: 30768393.
      View in: PubMed
    13. Cook IA, Wilson AC, Corlier J, Leuchter AF. Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study. Neuromodulation. 2019 Dec; 22(8):894-897. PMID: 30637862.
      View in: PubMed
    14. Voigt J, Carpenter L, Leuchter A. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder. BMC Psychiatry. 2019 01 08; 19(1):13. PMID: 30621636.
      View in: PubMed
    15. Philip NS, Leuchter AF, Cook IA, Massaro J, Goethe JW, Carpenter LL. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depress Anxiety. 2019 03; 36(3):278-285. PMID: 30480860.
      View in: PubMed
    16. Leuchter AF, Corlier J. A precision medicine approach to repetitive Transcranial Magnetic Stimulation (rTMS). Brain Stimul. 2018 May - Jun; 11(3):463-464. PMID: 29501433.
      View in: PubMed
    17. Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clin EEG Neurosci. 2018 Sep; 49(5):306-315. PMID: 29224411.
      View in: PubMed
    18. Voigt J, Carpenter L, Leuchter A. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis. PLoS One. 2017; 12(10):e0186950. PMID: 29073256.
      View in: PubMed
    19. Van Dyk K, Hunter AM, Ercoli L, Petersen L, Leuchter AF, Ganz PA. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography. Breast Cancer Res Treat. 2017 Nov; 166(1):157-166. PMID: 28707203.
      View in: PubMed
    20. Fogelson DL, Leuchter A. Defining Treatment-Resistant Depression. JAMA Psychiatry. 2017 07 01; 74(7):758-759. PMID: 28564677.
      View in: PubMed
    21. Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? Int Rev Psychiatry. 2017 04; 29(2):98-114. PMID: 28362541.
      View in: PubMed
    22. Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF. Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? Front Neurol. 2017; 8:91. PMID: 28424652.
      View in: PubMed
    23. Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. J Psychiatr Res. 2017 01; 84:174-183. PMID: 27770740.
      View in: PubMed
    24. Scanlon GC, Jain FA, Hunter AM, Cook IA, Leuchter AF. Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder. Clin EEG Neurosci. 2017 May; 48(3):159-167. PMID: 27000108.
      View in: PubMed
    25. Koek RJ, Schwartz HN, Scully S, Langevin JP, Spangler S, Korotinsky A, Jou K, Leuchter A. Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Prog Neuropsychopharmacol Biol Psychiatry. 2016 10 03; 70:170-218. PMID: 26854815.
      View in: PubMed
    26. Cook IA, Abrams M, Leuchter AF. Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Neuromodulation. 2016 Apr; 19(3):299-305. PMID: 26818103.
      View in: PubMed
    27. Leuchter AF, Hunter AM, Tartter M, Cook IA. Authors' reply. Br J Psychiatry. 2015 Dec; 207(6):561-2. PMID: 26628700.
      View in: PubMed
    28. Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology (Berl). 2015 Oct; 232(20):3833-40. PMID: 26319158.
      View in: PubMed
    29. Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O'Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015 Jul-Aug; 8(4):787-94. PMID: 26143022.
      View in: PubMed
    30. Leuchter AF, Hunter AM, Tartter M, Cook IA. Author's reply: To PMID 25213159. Br J Psychiatry. 2015 May; 206(5):435. PMID: 25934309.
      View in: PubMed
    31. Leuchter AF, Hunter AM, Krantz DE, Cook IA. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Ann N Y Acad Sci. 2015 May; 1344:78-91. PMID: 25809789.
      View in: PubMed
    32. Jain FA, Hunter AM, Leuchter AF, Brooks JO. A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. J Clin Psychiatry. 2015 Mar; 76(3):327. PMID: 25830451.
      View in: PubMed
    33. Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues Clin Neurosci. 2014 Dec; 16(4):525-37. PMID: 25733956.
      View in: PubMed
    34. McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA. An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder. Brain Stimul. 2015 Mar-Apr; 8(2):299-304. PMID: 25533244.
      View in: PubMed
    35. Caudill MM, Hunter AM, Cook IA, Leuchter AF. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clin EEG Neurosci. 2015 Oct; 46(4):277-84. PMID: 25258429.
      View in: PubMed
    36. Leuchter AF, Hunter AM, Tartter M, Cook IA. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. Br J Psychiatry. 2014 Dec; 205(6):443-9. PMID: 25213159.
      View in: PubMed
    37. Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D. Heart rate variability and treatment outcome in major depression: a pilot study. Int J Psychophysiol. 2014 Aug; 93(2):204-10. PMID: 24769434.
      View in: PubMed
    38. Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. J Psychiatr Res. 2014 Jul; 54:11-8. PMID: 24726639.
      View in: PubMed
    39. Cook IA, Hunter AM, Korb AS, Leuchter AF. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? J Psychiatr Res. 2014 Jun; 53:69-75. PMID: 24630467.
      View in: PubMed
    40. Hunter AM, Kwan L, Ercoli LM, Mills BK, Cook IA, Ganz PA, Leuchter AF. Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology. 2014 Jun; 23(6):713-5. PMID: 24890579.
      View in: PubMed
    41. Cook IA, Espinoza R, Leuchter AF. Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurg Clin N Am. 2014 Jan; 25(1):103-16. PMID: 24262903.
      View in: PubMed
    42. Ercoli LM, Castellon SA, Hunter AM, Kwan L, Kahn-Mills BA, Cernin PA, Leuchter AF, Ganz PA. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav. 2013 Dec; 7(4):543-53. PMID: 23955490.
      View in: PubMed
    43. Hunter AM, Cook IA, Abrams M, Leuchter AF. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Med Hypotheses. 2013 Dec; 81(6):1004-11. PMID: 24112999.
      View in: PubMed
    44. Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav. 2013 Aug; 28(2):221-6. PMID: 23773978.
      View in: PubMed
    45. Hunter AM, Leuchter AF, Power RA, Muthén B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP. A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res. 2013 Sep; 47(9):1157-65. PMID: 23726668.
      View in: PubMed
    46. Leuchter AF, Cook IA, Jin Y, Phillips B. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci. 2013; 7:37. PMID: 23550274.
      View in: PubMed
    47. Leuchter A, Simon SL, Daly KA, Rosenberg-Thompson S, Abrams M, Dunkin JJ, Cook IA, Newton TF, Walter DO, Cummings JL. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. Am J Geriatr Psychiatry. 1994 Summer; 2(3):200-209. PMID: 28530933.
      View in: PubMed
    48. Leuchter A, Simon SL, Daly KA, Abrams M, Rosenberg-Thompson S, Dunkin JJ, Cook IA, Newton TF, Spar JE. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. Am J Geriatr Psychiatry. 1994 Autumn; 2(4):290-299. PMID: 28530979.
      View in: PubMed
    49. Jain FA, Hunter AM, Brooks JO, Leuchter AF. Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety. 2013 Jul; 30(7):624-30. PMID: 23288666.
      View in: PubMed
    50. Hunter AM, Korb AS, Cook IA, Leuchter AF. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci. 2013; 25(2):126-33. PMID: 23686030.
      View in: PubMed
    51. Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry. 2013 Jan; 74(1):51-6. PMID: 23419226.
      View in: PubMed
    52. Leuchter A, Cook IA, Hunter AM. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. J Psychopharmacol. 2012 Aug; 26(8):1162-3; author reply 1164. PMID: 22807041.
      View in: PubMed
    53. Hunter AM, Cook IA, Leuchter AF. Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol. 2012 Oct; 22(10):711-20. PMID: 22445212.
      View in: PubMed
    54. Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One. 2012; 7(2):e32508. PMID: 22384265.
      View in: PubMed
    55. Kerber KB, Wisniewski SR, Luther JF, Leuchter AF, D'Empaire I, Trivedi MH, Rush AJ. Effects of heart disease on depression treatment: results from the COMED study. Gen Hosp Psychiatry. 2012 Jan-Feb; 34(1):24-34. PMID: 22001552.
      View in: PubMed
    56. Hunter AM, Cook IA, Greenwald SD, Tran ML, Miyamoto KN, Leuchter AF. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol. 2011 Oct; 28(5):478-82. PMID: 21946361.
      View in: PubMed
    57. Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res. 2011 Jun 30; 192(3):188-94. PMID: 21546222.
      View in: PubMed
    58. Muthén B, Asparouhov T, Hunter AM, Leuchter AF. Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychol Methods. 2011 Mar; 16(1):17-33. PMID: 21381817.
      View in: PubMed
    59. Hunter AM, Cook IA, Leuchter AF. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. J Clin Psychopharmacol. 2010 Dec; 30(6):748-51. PMID: 21057245.
      View in: PubMed
    60. Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD. Biomarkers to predict antidepressant response. Curr Psychiatry Rep. 2010 Dec; 12(6):553-62. PMID: 20963521.
      View in: PubMed
    61. Hunter A, Bordelon Y, Cook I, Leuchter A. QEEG Measures in Huntington's Disease: A Pilot Study. PLoS Curr. 2010 Oct 25; 2:RRN1192. PMID: 21037796.
      View in: PubMed
    62. Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ. Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol. 2010 Jun; 30(3):259-66. PMID: 20473060.
      View in: PubMed
    63. Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol. 2010 Apr; 30(2):193-7. PMID: 20520295.
      View in: PubMed
    64. Farahbod H, Cook IA, Korb AS, Hunter AM, Leuchter AF. Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clin EEG Neurosci. 2010 Jan; 41(1):19-23. PMID: 20307012.
      View in: PubMed
    65. Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res. 2009 Nov 30; 174(2):152-7. PMID: 19853417.
      View in: PubMed
    66. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 2009 Sep 30; 169(2):124-31. PMID: 19712979.
      View in: PubMed
    67. Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res. 2009 Sep 30; 169(2):132-8. PMID: 19709754.
      View in: PubMed
    68. Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009 Aug; 29(4):372-7. PMID: 19593178.
      View in: PubMed
    69. Hunter AM, Muthén BO, Cook IA, Leuchter AF. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res. 2010 Jan; 44(2):90-8. PMID: 19631948.
      View in: PubMed
    70. Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol. 2009 Jul; 120(7):1313-9. PMID: 19539524.
      View in: PubMed
    71. Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med. 2010 Feb; 40(2):239-51. PMID: 19493369.
      View in: PubMed
    72. Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE, Chappell AS. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med. 2009 May-Jun; 10(4):730-8. PMID: 19453962.
      View in: PubMed
    73. Leuchter AF, Cook IA, Hunter A, Korb A. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clin EEG Neurosci. 2009 Apr; 40(2):78-83. PMID: 19534301.
      View in: PubMed
    74. Leuchter AF, Cook IA, Hunter AM, Korb AS. A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci. 2009; 11(4):435-46. PMID: 20135901.
      View in: PubMed
    75. Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21(3):254-8. PMID: 19776303.
      View in: PubMed
    76. Korb AS, Cook IA, Hunter AM, Leuchter AF. Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr. 2008 Dec; 21(2):138-46. PMID: 18958615.
      View in: PubMed
    77. Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci. 2008 Oct; 39(4):175-81. PMID: 19044214.
      View in: PubMed
    78. Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract. 2008 Sep; 14(5):271-80. PMID: 18832958.
      View in: PubMed
    79. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008 Mar; 165(3):342-51. PMID: 18172020.
      View in: PubMed
    80. Shapiro D, Cook IA, Davydov DM, Ottaviani C, Leuchter AF, Abrams M. Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med. 2007 Dec; 4(4):493-502. PMID: 18227917.
      View in: PubMed
    81. Cook IA, Bookheimer SY, Mickes L, Leuchter AF, Kumar A. Aging and brain activation with working memory tasks: an fMRI study of connectivity. Int J Geriatr Psychiatry. 2007 Apr; 22(4):332-42. PMID: 17236244.
      View in: PubMed
    82. Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ. Insured and non-insured depressed outpatients: how do they compare? Ann Clin Psychiatry. 2007 Apr-Jun; 19(2):73-82. PMID: 17612846.
      View in: PubMed
    83. Hunter AM, Cook IA, Leuchter AF. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am. 2007 Mar; 30(1):105-24. PMID: 17362807.
      View in: PubMed
    84. Hunter AM, Leuchter AF, Morgan ML, Cook IA. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry. 2006 Aug; 163(8):1426-32. PMID: 16877657.
      View in: PubMed
    85. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 2007 Jan 20; 56(1):54-60. PMID: 16835012.
      View in: PubMed
    86. Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, Leuchter A, Wisniewski SR, Balasubramani GK, Alpert J. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord. 2007 Jan; 97(1-3):77-84. PMID: 16824617.
      View in: PubMed
    87. Moses T, Leuchter AF, Cook I, Abrams M. Does the clinical course of depression determine improvement in symptoms and quality of life? J Nerv Ment Dis. 2006 Apr; 194(4):241-8. PMID: 16614544.
      View in: PubMed
    88. Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. J Neuropsychiatry Clin Neurosci. 2006; 18(2):208-16. PMID: 16720798.
      View in: PubMed
    89. Krell HV, Leuchter AF, Cook IA, Abrams M. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics. 2005 Sep-Oct; 46(5):379-84. PMID: 16145181.
      View in: PubMed
    90. Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res. 2005 Sep; 39(5):461-6. PMID: 15992554.
      View in: PubMed
    91. Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ. Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatr Serv. 2005 Aug; 56(8):995-1004. PMID: 16088018.
      View in: PubMed
    92. Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology. 2005; 52(2):71-6. PMID: 15990459.
      View in: PubMed
    93. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry. 2005 Jun; 66(6):774-80. PMID: 15960574.
      View in: PubMed
    94. Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology. 2005 Apr; 30(4):792-9. PMID: 15637637.
      View in: PubMed
    95. Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry. 2004 Sep; 65(9):1174-9. PMID: 15367043.
      View in: PubMed
    96. Stubbeman WF, Leuchter AF, Cook IA, Shurman BD, Morgan M, Gunay I, Gonzalez S. Pretreatment neurophysiologic function and ECT response in depression. J ECT. 2004 Sep; 20(3):142-4. PMID: 15342997.
      View in: PubMed
    97. Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl). 2004 Dec; 177(1-2):15-22. PMID: 15252704.
      View in: PubMed
    98. Marie-Mitchell A, Leuchter AF, Chou CP, James Gauderman W, Azen SP. Predictors of improved mood over time in clinical trials for major depression. Psychiatry Res. 2004 Jun 30; 127(1-2):73-84. PMID: 15261707.
      View in: PubMed
    99. Cook IA, Leuchter AF, Morgan ML, Dunkin JJ, Witte E, David S, Mickes L, O'Hara R, Simon S, Lufkin R, Abrams M, Rosenberg S. Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):190-200. PMID: 15010348.
      View in: PubMed
    100. Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol. 2004 Jan; 115(1):194-8. PMID: 14706488.
      View in: PubMed
    101. Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol. 2003 Mar; 114(3):410-5. PMID: 12705421.
      View in: PubMed
    102. Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, Mody RK, Arora S, Zheng Z, Abrams M, Rosenberg-Thompson S. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol. 2002 Oct; 59(10):1612-20. PMID: 12374500.
      View in: PubMed
    103. Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry. 2002 Jul; 17(7):610-8. PMID: 12112157.
      View in: PubMed
    104. Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002 Jul; 27(1):120-31. PMID: 12062912.
      View in: PubMed
    105. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry. 2002 Jan; 159(1):122-9. PMID: 11772700.
      View in: PubMed